Literature DB >> 16868370

Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades.

Faleh Zaid Al-Faleh1.   

Abstract

BACKGROUND: Information on the epidemiology of viral hepatitis B, C and A in the Kingdom of Saudi Arabia (KSA) has accumulated over the last two decades. We review the changing epidemiology of these infections and suggest possible strategies for eradication.
METHODS: We screened Saudi medical journals and Medline for reports dealing with hepatitis B, C and A, and analyzed official of blood donor screening data from the Ministry of Health (MOH) Central Blood Bank and the King Khalid University Hospital (KKUH) Blood Bank.
RESULTS: Several studies from the 1980s found a high endemicity for HBV, with 5% to 10% of the population infected and prevalence varying from one region to another. In children (age 1 to 12 years), the prevalence was almost 7% in 1989, just before the addition of the HBV vaccine to the Extended Program of Immunization (EPI). By 1997, the prevalence of HBV infection in children had declined to 0.3%. Blood donor results have also shown a steady decrease in HBV infection. At KKUH, prevalence declined from 3.7% in 1987 to 1.7% in 2000. Hepatitis C infection has also shown a marked decline among Saudi blood donors at KKUH, HAV infection among children has declined from 50% in 1989 to 25% in 1997, but the infection rate is still high, reaching 50% in a few regions.
CONCLUSIONS: Hepatitis B, C, and A infection has declined in KSA in the last two decades by more than 50%. The reasons for this marked decline are multifactorial. An important reason is the adoption in the last two decades of the MOH strategy for prevention of viral hepatitis infection, which needs to continue. Improvements in the economic status of the population and the decline in illiteracy have also contributed to the decline in viral hepatitis infection.

Entities:  

Year:  2003        PMID: 16868370     DOI: 10.5144/0256-4947.2003.367

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  14 in total

1.  Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years.

Authors:  Faleh Al Faleh; Suliman Al Shehri; Saleh Al Ansari; Mohammed Al Jeffri; Yaqoub Al Mazrou; Ahmad Shaffi; Ayman-A Abdo
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

2.  Knowledge of hepatitis B and vaccination status of some expatriate ethnic groups of blue collar workers in northern saudi arabia.

Authors:  Abdul Satter Khan; Maisa Al-Sweilem; Zekeriya Akturk
Journal:  J Family Community Med       Date:  2008-05

3.  Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia.

Authors:  Abdulaziz T Alshomrani
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

4.  SASLT practice guidelines: management of hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Faisal M Sanai; Mona Ismail; Hamdan Alghamdi; Khalid Alswat; Adel Alqutub; Ibrahim Altraif; Hemant Shah; Faleh Z Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2012-09       Impact factor: 2.485

Review 5.  Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.

Authors:  Ziba Farajzadegan; Shervin Ghaffari Hoseini; Roya Kelishadi; Fahimeh Jamshidi; Zari Nokhodian; Rasool Noori; Parisa Mirmoghtadaee; Silva Hovsepian; Seyyed-Nassereddin Mostafavi
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

6.  Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia.

Authors:  Adnan Agha; Rafaat Chakik; Mamdouh M Abdulhadi Ali; Dib Alsaudi; Giorgio Sammito; Edoardo Giovanni Giannini
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

7.  Chronic hepatitis C in saudi arabia: three years local experience in a university hospital.

Authors:  Hisham O Akbar; Ahmad Al Ghamdi; Faten Qattan; Hind I Fallatah; Maha Al Rumani
Journal:  Hepat Mon       Date:  2012-09-30       Impact factor: 0.660

Review 8.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

9.  Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population.

Authors:  Khalid A Alswat; Faisal M Sanai; Mansour Altuwaijri; Ali Albenmousa; Majid Almadi; Waleed K Al-Hamoudi; Ayman A Abdo
Journal:  Hepat Mon       Date:  2013-05-08       Impact factor: 0.660

10.  Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: the need for national guidelines for health students.

Authors:  Jobran M Alqahtani; Saeed A Abu-Eshy; Ahmed A Mahfouz; Awad A El-Mekki; Ahmed M Asaad
Journal:  BMC Public Health       Date:  2014-06-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.